COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 138 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,890,056 | -5.3% | 129,309 | -9.0% | 0.00% | 0.0% |
| Q2 2023 | $3,052,053 | -19.7% | 142,022 | -10.3% | 0.00% | -33.3% |
| Q1 2023 | $3,800,376 | +8.2% | 158,415 | +4.6% | 0.00% | 0.0% |
| Q4 2022 | $3,513,942 | +54.9% | 151,463 | +7.0% | 0.00% | +50.0% |
| Q3 2022 | $2,268,000 | -23.4% | 141,580 | -15.2% | 0.00% | -33.3% |
| Q2 2022 | $2,959,000 | -13.0% | 166,977 | -0.1% | 0.00% | 0.0% |
| Q1 2022 | $3,402,000 | +15.1% | 167,085 | +5.6% | 0.00% | +50.0% |
| Q4 2021 | $2,956,000 | -19.9% | 158,235 | -15.4% | 0.00% | -33.3% |
| Q3 2021 | $3,690,000 | -19.3% | 186,942 | -3.3% | 0.00% | -40.0% |
| Q2 2021 | $4,571,000 | -1.3% | 193,374 | -1.0% | 0.01% | 0.0% |
| Q1 2021 | $4,629,000 | +19.0% | 195,335 | +0.6% | 0.01% | 0.0% |
| Q4 2020 | $3,889,000 | -6.6% | 194,154 | -2.9% | 0.01% | -28.6% |
| Q3 2020 | $4,163,000 | +12.4% | 199,934 | -5.6% | 0.01% | +16.7% |
| Q2 2020 | $3,705,000 | +6.4% | 211,688 | -0.8% | 0.01% | -25.0% |
| Q1 2020 | $3,483,000 | -20.9% | 213,310 | -0.3% | 0.01% | 0.0% |
| Q4 2019 | $4,405,000 | +84.4% | 214,022 | +2.8% | 0.01% | +60.0% |
| Q3 2019 | $2,389,000 | -12.7% | 208,101 | -0.1% | 0.01% | -16.7% |
| Q2 2019 | $2,738,000 | -8.9% | 208,232 | +4.9% | 0.01% | -14.3% |
| Q1 2019 | $3,004,000 | -12.5% | 198,424 | -0.8% | 0.01% | -22.2% |
| Q4 2018 | $3,435,000 | +16.0% | 200,043 | -0.4% | 0.01% | +28.6% |
| Q3 2018 | $2,961,000 | -35.4% | 200,863 | +4.5% | 0.01% | -41.7% |
| Q2 2018 | $4,586,000 | +12.6% | 192,305 | +20.6% | 0.01% | +9.1% |
| Q1 2018 | $4,074,000 | +46.1% | 159,456 | +5.5% | 0.01% | +37.5% |
| Q4 2017 | $2,789,000 | +87.2% | 151,085 | +6.4% | 0.01% | +60.0% |
| Q3 2017 | $1,490,000 | -16.3% | 142,003 | -0.2% | 0.01% | -28.6% |
| Q2 2017 | $1,781,000 | +51.8% | 142,336 | +18.8% | 0.01% | -12.5% |
| Q1 2017 | $1,173,000 | -37.0% | 119,801 | +0.9% | 0.01% | -42.9% |
| Q4 2016 | $1,861,000 | -22.3% | 118,703 | -0.3% | 0.01% | -39.1% |
| Q3 2016 | $2,396,000 | +100.0% | 119,071 | +24.2% | 0.02% | +130.0% |
| Q2 2016 | $1,198,000 | -39.1% | 95,898 | -11.4% | 0.01% | +100.0% |
| Q1 2016 | $1,968,000 | +56.2% | 108,290 | +105.9% | 0.01% | +66.7% |
| Q4 2015 | $1,260,000 | – | 52,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |